1. Home
  2. SPNT vs PGEN Comparison

SPNT vs PGEN Comparison

Compare SPNT & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiriusPoint Ltd.

SPNT

SiriusPoint Ltd.

HOLD

Current Price

$25.17

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$7.70

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPNT
PGEN
Founded
2011
1998
Country
Bermuda
United States
Employees
N/A
47
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
SPNT
PGEN
Price
$25.17
$7.70
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$27.50
$8.33
AVG Volume (30 Days)
567.5K
3.7M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
250.00
N/A
EPS
1.40
0.03
Revenue
$3,205,100,000.00
$230,981,000.00
Revenue This Year
$0.85
$1,115.92
Revenue Next Year
$5.85
$81.04
P/E Ratio
$17.59
$258.83
Revenue Growth
23.09
N/A
52 Week Low
$17.35
$2.99
52 Week High
$26.48
$8.04

Technical Indicators

Market Signals
Indicator
SPNT
PGEN
Relative Strength Index (RSI) 63.14 64.70
Support Level $22.22 $6.57
Resistance Level $26.48 $7.72
Average True Range (ATR) 0.52 0.27
MACD 0.05 0.05
Stochastic Oscillator 96.28 76.41

Price Performance

Historical Comparison
SPNT
PGEN

About SPNT SiriusPoint Ltd.

SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: